Showing results (141-150 of 3,292) with videos related to
Sort By:
Pageof 330
Forum for Health Economics & Policy|April 25, 2019
The Impact of New Drug Launches on Hospitalization in 2015 for 67 Medical Conditions in 15 OECD Countries: A Two-Way Fixed-Effects AnalysisFrank R LichtenbergThe European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 29, 2011
The impact of new (orphan) drug approvals on premature mortality from rare diseases in the United States and France, 1999-2007Frank R LichtenbergExpert Review of Pharmacoeconomics & Outcomes Research|January 8, 2020
How cost-effective are new cancer drugs in the U.S.?Frank R LichtenbergEconomics and Human Biology|October 7, 2004
The effect of new drug approvals on HIV mortality in the US, 1987-1998Frank R LichtenbergThe Psychoanalytic Quarterly|May 14, 2005
Sanderian activation waves: a hypothesis of a nonsymbolic influence on moodsJoseph D LichtenbergEconomics and Human Biology|May 14, 2013
The impact of pharmaceutical innovation on longevity and medical expenditure in France, 2000-2009Frank R LichtenbergOccupational Therapy in Health Care|December 21, 2013
Sexuality and physical intimacy in long-term carePeter A LichtenbergPublic Health|November 19, 2020
Are estimates of 'potential gains in life expectancy' potentially unreliable?F R LichtenbergParasitology|January 1, 1987
The Wellcome Trust lecture. Inflammatory responses to filarial connective tissue parasitesF von LichtenbergThe Journal of Medicine and Philosophy|January 7, 2006
Pharmaceutical innovation and the burden of disease in developing and developed countriesFrank R LichtenbergPageof 330